Study designed as single ascending dose to determine safety, tolerability and pharmacokinetics in healthy volunteers Future development in complement-mediated chronic diseases JENA, Germany, Nov. 09, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback